U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166887) titled 'Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male' on Aug. 22.
Brief Summary: pharmacokinetics, pharmacological effects and safety of multi dose of 7.5mg Tolvaptan tablet in healthy male subjects
Study Start Date: June 07, 2011
Study Type: INTERVENTIONAL
Condition:
Healthy Subjects
Intervention:
DRUG: Tolvaptan
One dose on the first day and one dose on days 3-9, for a total of eight doses.
Recruitment Status: COMPLETED
Sponsor: Otsuka Beijing Research Institute
Published by HT Digital Content Services with permission from Health Daily Digest....